Telomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophageal squamous cell carcinoma: A genome-wide analysis

Cancer Research

Volumn 69, Issue 4, 2009, Pages 1604-1614

  Zheng, Yun Ling ^a   Hu, Nan ^b   Sun, Qing ^a   Wang, Chaoyu ^b   Taylor, Philip R ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CELL; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENETIC ANALYSIS; HUMAN; IN SITU HYBRIDIZATION; MALE; MUTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; STROMA CELL; TELOMERE;

CARCINOMA, SQUAMOUS CELL; CHINA; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 15; ESOPHAGEAL NEOPLASMS; GENOME, HUMAN; HUMANS; LIFE STYLE; LOSS OF HETEROZYGOSITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; STROMAL CELLS; TELOMERE;

EID: 60649088156     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3028     Document Type: Article

References (53)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982;62:113-20.
3. Qiao YL, Hou J, Yang L, et al. [The trends and preventive strategies of esophageal cancer in high-risk areas of Taihang Mountains, China]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2001;23:10-4.
4. Yang CS. Research on esophageal cancer in China: a review. Cancer Res 1980;40:2633-44.
5. Wang YP, Han XY, Su W, et al. Esophageal cancer in Shanxi Province, People's Republic of China: a case-control study in high and moderate risk areas. Cancer Causes Control 1992;3:107-13.
6. Hu N, Dawsey SM,Wu M,etal. Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol 1992; 21:877-82.
7. Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol 1997;26:1159-65.
8. Li XY, Su M, Huang HH, Li H, Tian DP, Gao YX. mtDNA evidence: genetic background associated with related populations at high risk for esophageal cancer between Chaoshan and Taihang Mountain areas in China. Genomics 2007;90:474-81.
9. Hu N, Wang C, Hu Y, et al. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array. BMC Genomics 2006;7: 299-314.
10. Hu N, Roth MJ, Polymeropolous M, et al. Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high- risk Chinese population. Genes Chromosomes Cancer 2000;27:217-28.
11. Hu N, Su H, Li WJ, et al. Allelotyping of esophageal squamous-cell carcinoma on chromosome 13 defines deletions related to family history. Genes Chromosomes Cancer 2005;44:271-8.
12. Hu N, Roth MJ, Emmert-BuckMR, etal. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin Cancer Res 1999;5:3476-82.
13. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
14. Hackett JA, Feldser DM, Greider CW. Telomere dysfunction increases mutation rate and genomic instability. Cell 2001;106:275-86.
15. Gisselsson D, Jonson T, Petersen A, et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 2001;98:12683-8.
16. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002;297:565-9.
17. Fang DC, Yang SM, Zhou XD, Wang DX, Luo YH. Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J Gastroenterol 2001;7:522-6.
18. Maruyama Y, Hanai H, Fujita M, Kaneko E. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol 1997;27:216-20.
19. Engelhardt M, Drullinsky P, Guillem J, Moore MA. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997;3:1931-41.
20. Lantuejoul S, Soria JC, Morat L, et al. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions. Clin Cancer Res 2005;11:2074-82.
21. Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Marzo AM, Argani P. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol 2004;164:925-35.
22. van Heek NT, Meeker AK, Kern SE, et al. Telomere shortening is nearly universal in pancreatic intra-epithelial neoplasia. Am J Pathol 2002;161:1541-7.
23. Meeker AK, Hicks JL, Platz EA, et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 2002;62:6405-9.
24. Finley JC, Reid BJ, Odze RD, et al. Chromosomal instability in Barrett's esophagus is related to telomere shortening. Cancer Epidemiol Biomarkers Prev 2006;15: 1451-7.
25. Kammori M, Izumiyama N, Nakamura K, et al. Telomere metabolism and diagnostic demonstration of telomere measurement in the human esophagus for distinguishing benign from malignant tissue by tissue quantitative fluorescence in situ hybridization. Oncology 2006;71:430-6.
26. Kammori M, Poon SS, Nakamura K, et al. Squamous cell carcinomas of the esophagus arise from a telomere-shortened epithelial field. Int J Mol Med 2007;20:793-9.
27. Risques RA, Vaughan TL, Li X, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16: 2649-55.
28. Akbay EA, Contreras CM, Perera SA, et al. Differential roles of telomere attrition in type I and II endometrial carcinogenesis. Am J Pathol 2008;173:536-44.
29. Joshua AM, Vukovic B, Braude I, et al. Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia 2007;9:81-9.
30. O'Sullivan JN, Bronner MP, Brentnall TA, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002;32:280-4.
31. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
32. Mathieu N, Pirzio L, Freulet-Marriere MA, Desmaze C, Sabatier L. Telomeres and chromosomal instability. Cell Mol Life Sci 2004;61:641-56.
33. Bailey SM, Murnane JP. Telomeres, chromosome instability and cancer. Nucleic Acids Res 2006;34: 2408-17.
34. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
35. Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-49.
36. Dolberg DS, Hollingsworth R, Hertle M, Bissell MJ. Wounding and its role in RSV-mediated tumor formation. Science 1985;230:676-8.
37. Sieweke MH, Thompson NL, Sporn MB, Bissell MJ. Mediation of wound-related Rous sarcoma virus tumor-igenesis by TGF-h. Science 1990;248:1656-60.
38. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
39. Hawsawi NM, Ghebeh H, Hendrayani SF, et al. Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 2008;68: 2717-25.
40. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001;107:67-77.
41. Lansdorp PM, Verwoerd NP, van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996;5:685-91.
42. Graakjaer J, Bischoff C, Korsholm L, et al. The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech Ageing Dev 2003;124:629-40.
43. Martens UM, Zijlmans JM, Poon SS, et al. Short telomeres on human chromosome 17p. Nat Genet 1998; 18:76-80.
44. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994;55: 876-82.
45. Graakjaer J, Pascoe L, Der-Sarkissian H, et al. The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell 2004;3:97-102.
46. Britt-Compton B, Rowson J, Locke M, Mackenzie I, Kipling D, Baird DM. Structural stability and chromosome-specific telomere length is governed by cis acting determinants in humans. Hum Mol Genet 2006; 15:725-33.
47. Der-Sarkissian H, Bacchetti S, Cazes L, Londono- Vallejo JA. The shortest telomeres drive karyotype evolution in transformed cells. Oncogene 2004;23: 1221-8.
48. Soler D, Genesca A, Arnedo G, Egozcue J, Tusell L. Telomere dysfunction drives chromosomal instability in human mammary epithelial cells. Genes Chromosomes Cancer 2005;44:339-50.
49. Rashid-Kolvear F, Pintilie M, Done SJ. Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer. Neoplasia 2007;9:265-70.
50. Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: biological and clinical importance. Clin Chem 1997;43:708-14.
51. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, et al. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 2004;10:3317-26.
52. Hiyama K, Ishioka S, Shirotani Y, et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995;10:937-44.
53. Albanell J, Bosl GJ, Reuter VE, et al. Telomerase activity in germ cell cancers and mature teratomas. J Natl Cancer Inst 1999;91:1321-6.